文献检索/Drug SafetyEM-T3Drug Safety2026-01-28第 49 卷第 5 期,519-528Physician Awareness of FDA’s Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 PandemicCatherine S. HwangBrigham and Women's HospitalZhigang LuBrigham and Women's HospitalMassimiliano RussoBrigham and Women's HospitalHeidi ZakoulBrigham and Women's HospitalGita A. ToyserkaniUnited States Food and Drug AdministrationEsther H. ZhouUnited States Food and Drug AdministrationCynthia LaCivitaUnited States Food and Drug AdministrationGerald J. Dal PanUnited States Food and Drug AdministrationAaron Seth KesselheimBrigham and Women's HospitalAmeet SarpatwariBrigham and Women's Hospital去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱,注册免费。登录 / 注册关键词risk evaluation and mitigation strategyREMSlaboratory monitoringphysician awarenessCOVID-19 pandemicprescribing patternsambrisentanbosentanclozapineisotretinoinlenalidomidepomalidomidethalidomidepharmacovigilancephysician characteristicspractice environmentrace参考文献17引证文献0相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱:谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册